The Cavity Germ in Your Mouth May Also Play a Role in Parkinson's Disease

Scientists have long known that Streptococcus mutans, the bacterium most closely associated with tooth decay, lives in dental plaque. A study published in Nature Communications and widely reported in early 2026 adds a far less familiar concern:

Korean researchers found that S. mutans, when it colonizes the gut, produces an enzyme called urocanate reductase and a downstream metabolite called imidazole propionate, both of which were detected at elevated levels in the gut and blood of people with Parkinson's disease.

Once the bacteria are established in the gut, those metabolites can travel to the brain and contribute to the loss of dopaminergic neurons — the nerve-cell loss that drives Parkinson's development — further underscoring the role of the so-called gut-brain axis in the disease.

To test causation,

the team introduced S. mutans into mice or engineered gut bacteria to produce the same enzyme; in both cases, metabolite levels rose in blood and brain tissue, and the animals developed signs consistent with Parkinson's, including damaged dopaminergic neurons, increased brain inflammation, and movement difficulties.

The researchers analyzed stool samples from nearly 500 patients with Parkinson's and 234 healthy controls

to build their microbial profile.

The findings suggest that targeting the oral-gut microbiome could open new strategies for preventing or treating the disease.

Researchers are careful to note that a connection between two things does not prove one causes the other, and much more work in humans will be needed before any clinical conclusions can be drawn.

For patients, the study adds a neurological dimension to the already substantial reasons to keep S. mutans in check.

S. mutans is the bacterium normally seen in a person's mouth and strongly linked to dental cavities

, meaning the same daily habits that protect teeth — brushing, flossing, and regular professional cleanings — are also the front line of defense against the bacterium accumulating in the first place. Researchers say the findings point toward a future where oral health monitoring could inform risk assessment for certain neurological conditions, though that application remains years away.